Diabetes drug LixiLan shows promising results in clinical trial
from World Report Now
French pharmaceutical company Sanofi declared in a statement Sept. 14 that its Type 2 diabetes medication has showed promising results during its final clinical trial. If the drug, called LixiLan, will be passing the regulatory reviews of the health officials, it will become available in drugstores across the United States and European Union starting the first quarter of 2016.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063